−1.10USD
−15.20 MUSD
18.28 MUSD
14.93 M
About Ekso Bionics Holdings, Inc.
Sector
Industry
CEO
Scott Davis
Website
Headquarters
San Rafael
Employees (FY)
70
Founded
2012
ISIN
US2826443010
FIGI
BBG002Z0NKK4
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EKSO is 1.21 USD — it has decreased by 5.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ekso Bionics Holdings, Inc. stocks are traded under the ticker EKSO.
Ekso Bionics Holdings, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
EKSO stock is 12.17% volatile and has beta coefficient of 2.12. Check out the list of the most volatile stocks — is Ekso Bionics Holdings, Inc. there?
One year price forecast for Ekso Bionics Holdings, Inc. has a max estimate of 9.25 USD and a min estimate of 9.25 USD.
EKSO earnings for the last quarter are −0.24 USD whereas the estimation was −0.31 USD which accounts for 22.58% surprise. Estimated earnings for the next quarter are −0.11 USD. See more details about Ekso Bionics Holdings, Inc. earnings.
Ekso Bionics Holdings, Inc. revenue for the last quarter amounts to 4.61 M USD despite the estimated figure of 4.50 M USD. In the next quarter revenue is expected to reach 4.80 M USD.
Yes, you can track Ekso Bionics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
EKSO stock has fallen by 4.72% compared to the previous week, the month change is a 10.37% fall, over the last year Ekso Bionics Holdings, Inc. has showed a 26.67% decrease.
EKSO net income for the last quarter is −3.21 M USD, while the quarter before that showed −3.37 M USD of net income which accounts for 4.49% change. Track more Ekso Bionics Holdings, Inc. financial stats to get the full picture.
Today Ekso Bionics Holdings, Inc. has the market capitalization of 22.92 M, it has decreased by 5.67% over the last week.
No, EKSO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EKSO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ekso Bionics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 70.00 employees. See our rating of the largest employees — is Ekso Bionics Holdings, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ekso Bionics Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ekso Bionics Holdings, Inc. stock shows the sell signal. See more of Ekso Bionics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Ekso Bionics Holdings, Inc. future price: according to them, EKSO price has a max estimate of 9.25 USD and a min estimate of 9.25 USD. Read a more detailed Ekso Bionics Holdings, Inc. forecast: see what analysts think of Ekso Bionics Holdings, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ekso Bionics Holdings, Inc. EBITDA is −13.41 M USD, and current EBITDA margin is −73.38%. See more stats in Ekso Bionics Holdings, Inc. financial statements.